Drug
FAPI-46 clinical trials
Includes 7 studies of FAPI-46 GA-68.
- studies test it
- 14
- open now
- 7
- in phase 3
- 0
- first study started
- 2020
Keep track of what changes. Save the FAPI-46 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
13 studies that test it; most in 2022 (3); 1 more planned to start later
| Year | Studies |
|---|---|
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 3
- Phase 1
- 2
- Phase 2
- 8
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 13
Jonsson Comprehensive Cancer Center (2) · Aalborg University Hospital (2) · Barbara Malene Fischer (2) · University of California, Los Angeles (1) · SOFIE (1) · Nantes University Hospital (1) · Mayo Clinic (1) · Universität Münster (1)
Studies
Open first, then newest update. How each study uses FAPI-46 is read from its arms, and is right about nine times in ten.
Testing it · 14
- Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac AmyloidosisRecruitingPhase 2Nantes University HospitalNCT07549841Written as [68Ga]Ga-FAPI-46
- Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal AdenocarcinomaRecruitingPhase 2Mayo ClinicNCT05518903Written as Gallium Ga 68 FAPi-46
- BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in CancerRecruitingPhase 2Barbara Malene FischerNCT07629609Written as [68Ga]Ga-FAPI-46
- Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive CancerRecruitingPhase 2Universität MünsterNCT06540872Written as [68Ga]Ga-FAPI-46
- [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in CancerRecruitingPhase 2Barbara Malene FischerNCT07215182Written as [68Ga]Ga-FAPI-46
- FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown PrimaryRecruitingNot applicablePeter MacCallum Cancer Centre, AustraliaNCT05263700Written as 68Ga-FAPi-46
- PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPIRecruitingPhase 1Karolinska University HospitalNCT05172310Written as 68Ga-FAPI-46
- 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With SarcomaActive, not recruitingEarly Phase 1Jonsson Comprehensive Cancer CenterNCT04457258Written as Gallium Ga 68 FAPi-46
- FAPI PET for Lung FibrosisActive, not recruitingEarly Phase 1University of California, Los AngelesNCT05365802Written as 68Ga-FAPi-46
- Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal CarcinomaCompletedPhase 2SOFIENCT05262855Written as [68Ga]FAPI-46
- [68Ga]Ga-FAPI-46 PET/CT in Ovarian CancerTerminatedPhase 2Aalborg University HospitalNCT05903807Written as 68Ga-FAPi-46
- Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various CancersActive, not recruitingPhase 1Jonsson Comprehensive Cancer CenterNCT04459273Written as Gallium Ga 68 FAPi-46
- Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor PatientsWithdrawnEarly Phase 1Eben RosenthalNCT06922825Written as 68Ga-FAPI-46
- [68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional CancerCompletedPhase 2Aalborg University HospitalNCT05898854Written as 68Ga-FAPi-46
Codes
What other systems call FAPI-46 · ClinicalTrials.gg INT001310
- MeSH (NLM) C000706531FAPI-46One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000706531 | FAPI-46 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.